MIRA Pharmaceuticals, Inc. Common Stock (MIRA) financials · $41.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) $41.1M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $11.1M | $2.92M |
| Current Assets | $11.1M | $2.89M |
| Cash & Equivalents | $6.35M | $2.83M |
| Total Liabilities | $702.1K | $723.3K |
| Current Liabilities | $702.1K | $723.3K |
| Shareholders' Equity | $10.4M | $2.20M |
| Retained Earnings | -$39.6M | -$29.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$4.66M | -$5.56M |
| Financing Cash Flow | $8.18M | $3.79M |
| Net Change in Cash | $3.51M | -$1.77M |
FAQ
What is MIRA P/E and revenue?
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) $41.1M cap.
What is MIRA revenue?
MIRA income-statement cache has no revenue figure yet.
Is MIRA profitable?
MIRA Pharmaceuticals, Inc. Common Stock last cached net income is -$10.4M (FY2025).
What are MIRA total assets?
MIRA Pharmaceuticals, Inc. Common Stock last cached total assets are $11.1M (FY2025).
What is MIRA free cash flow?
No cached cash-flow row for MIRA yet.
Not investment advice. Cached statements, not a live tape.